Injections of a type 2 diabetes drug could be a ‘game changer’ for cardiovascular patients by cutting the risk of heart attacks or strokes.
A study led by researchers at University College London found that participants who took the drug had a 20% lower risk of cardiovascular disease, regardless of how much weight they lost.